Point Of Care Diagnostics Market
Point-of-Care Diagnostics Market Forecasts to 2030 - Global Analysis By Product Type (Glucose Monitoring Kits, Infectious Disease Testing Kits, Hematology Testing Kits, Cholesterol Testing Kits, Pregnancy and Fertility Testing Kits, Coagulation Monitoring Kit, Urinalysis Testing Kits, Drug Abuse Testing Kits, Cardiac Markers, Thyroid Stimulating Hormone Testing, Blood Gas/Electrolytes and Other Product Types), Platform, Prescription, Sample, Application, End User and By Geography
According to Stratistics MRC, the Global Point-of-Care Diagnostics Market is accounted for $33.4 billion in 2024 and is expected to reach $53.5 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Point-of-Care (POC) Diagnostics are medical testing conducted at or near the site of patient care. This approach allows for rapid diagnosis and immediate treatment, enhancing patient outcomes and reducing the need for follow-up visits. POC diagnostics encompass a range of tests, including blood glucose monitoring, pregnancy tests, infectious disease detection, and cardiac markers. The technology used in POC diagnostics is designed to be user-friendly, often requiring minimal training for healthcare providers or even patients. These tests provide quick results, which are crucial in critical care settings, remote locations, and in managing chronic diseases. The convenience and speed of POC diagnostics help in making informed clinical decisions promptly, thus improving the efficiency of healthcare delivery.
According to 2021 data published by the Centers for Disease Control and Prevention (CDC), there are approximately 38.4 million people with diabetes in the U.S.
Market Dynamics:
Driver:
Rising prevalence of chronic and infectious diseases
Chronic diseases like diabetes, cancer, and heart disease are becoming increasingly common around the world, due to factors like aging populations, unhealthy lifestyles, and environmental changes. POC tests can help with early detection and management of these conditions. Infectious diseases like COVID-19, HIV, and tuberculosis are also a major driver, as POC tests enable rapid diagnosis and intervention which boosts the growth of the market.
Restraint:
Strict regulatory requirements
Strict regulatory requirements often involve rigorous testing, documentation, and approval processes that can be time-consuming and costly. Consequently, companies may face delays in bringing new POC diagnostic devices to market, hindering innovation and reducing the speed at which advancements can benefit patients. The high costs associated with meeting regulatory standards can be particularly challenging for smaller companies and startups, potentially limiting their ability to compete and stifling diversity in the market.
Opportunity:
Shift towards decentralized healthcare
Decentralized healthcare model emphasizes providing medical care closer to the patient, outside traditional hospital settings. As a result, the demand for rapid, portable, and easy-to-use diagnostic tools has surged. POC diagnostics enable immediate testing and decision-making at the patient’s location, be it a home, clinic, or remote area, aligning perfectly with the goals of decentralized healthcare. This shift enhances accessibility to diagnostic services, especially in underserved and rural areas, reducing the need for extensive lab infrastructure.
Threat:
Accuracy and reliability concerns
POC diagnostic tools sometimes exhibit variability in results compared to traditional laboratory tests. This discrepancy can undermine healthcare professionals' and patients' confidence in these tools, leading to reluctance in their widespread adoption. Inaccurate or inconsistent results can result in misdiagnoses, inappropriate treatment plans, and ultimately poorer patient outcomes, which are critical concerns in medical practice. Moreover, healthcare providers may require additional confirmatory tests from centralized laboratories to verify POC results, counteracting the primary advantage of rapid diagnosis.
Covid-19 Impact:
The Covid-19 pandemic had a profound impact on the Point-of-Care (POC) Diagnostics market. The urgent need for rapid, accurate, and accessible testing solutions led to an unprecedented surge in demand for POC diagnostic tools. Governments and healthcare systems globally prioritized POC tests for quick detection and monitoring of the virus, accelerating innovation and adoption of these technologies. Regulatory bodies also expedited approval processes, allowing for faster market entry. However, supply chain disruptions and the intense focus on Covid-19 diagnostics temporarily overshadowed the development and availability of POC tests for other conditions.
The glucose monitoring kits segment is expected to be the largest during the forecast period
The glucose monitoring kits is expected to be the largest during the forecast period as these kits, essential for diabetes management, exemplify the benefits of POC diagnostics, enabling real-time monitoring and immediate decision-making for patients. Their widespread adoption has driven technological advancements and consumer acceptance in the POC market. Moreover, the success of glucose monitoring kits has spurred innovation and investment in developing similar POC diagnostic tools for other chronic conditions, thereby expanding the market and improving overall healthcare delivery.
The molecular diagnostics segment is expected to have the highest CAGR during the forecast period
The molecular diagnostics segment is expected to have the highest CAGR during the forecast period because these advanced techniques allow for the rapid identification of genetic material from pathogens, leading to precise diagnostics for infectious diseases, genetic disorders, and cancer. The integration of molecular diagnostics into POC settings has driven innovation, resulting in portable, user-friendly devices capable of delivering lab-quality results quickly. This advancement has expanded the applications of POC diagnostics, improved patient outcomes through timely intervention.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to high prevalence of chronic diseases, an aging population, and a strong emphasis on early diagnosis and personalized medicine. The region benefits from advanced healthcare infrastructure, significant healthcare expenditure, and robust research and development activities. Moreover in the United States and Canada, there is a strong adoption of POC diagnostics in various settings, including hospitals, clinics, and home care. The Covid-19 pandemic further accelerated the demand for rapid and accurate POC testing, highlighting its importance in managing public health emergencies drives the market growth in this region.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period because regulatory bodies like the FDA play a crucial role in shaping the market by ensuring the safety and efficacy of POC diagnostic devices. Additionally, technological advancements, such as the integration of artificial intelligence and mobile health technologies, are driving innovation and expanding the capabilities of POC diagnostics.
Key players in the market
Some of the key players in Point-of-Care Diagnostics market include Abbott, AccuBioTech Co., Ltd, Anbio Biotechnology Co., Ltd., Becton, Dickinson and Company, bioMérieux S.A., Chembio Diagnostics, Danaher Corporation, EKF Diagnostics, F. Hoffman-La Roche Ltd., Instrumentation Laboratory, Nova Biomedical, Orasure Technologies, Inc., PTS Diagnostics, Qiagen, Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Trinity Biotech and Werfen
Key Developments:
In June 2024, Abbott and the National Association of Community Health Centers (NACHC) have joined together to increase access to healthy foods and improve health through the Innovation Incubator initiative.
In June 2024, BD (Becton, Dickinson and Company) and Edwards Lifesciences today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group (""Critical Care""), for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
In March 2024, Abbott, Real Madrid and the Real Madrid Foundation announced the extension of their partnership through Real Madrid's 2026-27 seasons. Abbott will remain Global Health Sciences and Nutrition Partner of Real Madrid Football Club and Global Partner of the Real Madrid Foundation.
Product Types Covered:
• Glucose Monitoring Kits
• Infectious Disease Testing Kits
• Hematology Testing Kits
• Cholesterol Testing Kits
• Pregnancy and Fertility Testing Kits
• Coagulation Monitoring Kit
• Urinalysis Testing Kits
• Drug Abuse Testing Kits
• Cardiac Markers
• Thyroid Stimulating Hormone Testing
• Blood Gas/Electrolytes
• Other Product Types
Platforms Covered:
• Dipsticks
• Lateral Flow Assays
• Microfluidics
• Molecular Diagnostics
• Immunoassays
• Other Platforms
Prescriptions Covered:
• Prescription Based
• Over The Counter Testing
Samples Covered:
• Blood
• Nasal & Oropharyngeal Swabs
• Urine
• Other Samples
Applications Covered:
• Infectious Diseases
• Cardiology
• Diabetes
• Oncology
• Hematology
• Pregnancy & Fertility
• Cholesterol
• Other Applications
End Users Covered:
• Hospitals
• Clinics & Ambulatory Care Centers
• Home Care Settings
• Diagnostic Laboratories
• Academic & Research Institutes
• Pharmacies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Point-of-Care Diagnostics Market, By Product Type
5.1 Introduction
5.2 Glucose Monitoring Kits
5.3 Infectious Disease Testing Kits
5.4 Hematology Testing Kits
5.5 Cholesterol Testing Kits
5.6 Pregnancy and Fertility Testing Kits
5.7 Coagulation Monitoring Kit
5.8 Urinalysis Testing Kits
5.9 Drug Abuse Testing Kits
5.10 Cardiac Markers
5.11 Thyroid Stimulating Hormone Testing
5.12 Blood Gas/Electrolytes
5.13 Other Product Types
6 Global Point-of-Care Diagnostics Market, By Platform
6.1 Introduction
6.2 Dipsticks
6.3 Lateral Flow Assays
6.4 Microfluidics
6.5 Molecular Diagnostics
6.6 Immunoassays
6.7 Other Platforms
7 Global Point-of-Care Diagnostics Market, By Prescription
7.1 Introduction
7.2 Prescription Based
7.3 Over The Counter Testing
8 Global Point-of-Care Diagnostics Market, By Sample
8.1 Introduction
8.2 Blood
8.3 Nasal & Oropharyngeal Swabs
8.4 Urine
8.5 Other Samples
9 Global Point-of-Care Diagnostics Market, By Application
9.1 Introduction
9.2 Infectious Diseases
9.3 Cardiology
9.4 Diabetes
9.5 Oncology
9.6 Hematology
9.7 Pregnancy & Fertility
9.8 Cholesterol
9.9 Other Applications
10 Global Point-of-Care Diagnostics Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Clinics & Ambulatory Care Centers
10.4 Home Care Settings
10.5 Diagnostic Laboratories
10.6 Academic & Research Institutes
10.7 Pharmacies
10.8 Other End Users
11 Global Point-of-Care Diagnostics Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott
13.2 AccuBioTech Co., Ltd
13.3 Anbio Biotechnology Co., Ltd.
13.4 Becton, Dickinson and Company
13.5 bioMérieux S.A.
13.6 Chembio Diagnostics
13.7 Danaher Corporation
13.8 EKF Diagnostics
13.9 F. Hoffman-La Roche Ltd.
13.10 Instrumentation Laboratory
13.11 Nova Biomedical
13.12 Orasure Technologies, Inc.
13.13 PTS Diagnostics
13.14 Qiagen
13.15 Sekisui Diagnostics
13.16 Siemens Healthineers AG
13.17 Thermo Fisher Scientific
13.18 Trinity Biotech
13.19 Werfen
List of Tables
1 Global Point-of-Care Diagnostics Market Outlook, By Region (2022-2030) ($MN)
2 Global Point-of-Care Diagnostics Market Outlook, By Product Type (2022-2030) ($MN)
3 Global Point-of-Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2022-2030) ($MN)
4 Global Point-of-Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2022-2030) ($MN)
5 Global Point-of-Care Diagnostics Market Outlook, By Hematology Testing Kits (2022-2030) ($MN)
6 Global Point-of-Care Diagnostics Market Outlook, By Cholesterol Testing Kits (2022-2030) ($MN)
7 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2022-2030) ($MN)
8 Global Point-of-Care Diagnostics Market Outlook, By Coagulation Monitoring Kit (2022-2030) ($MN)
9 Global Point-of-Care Diagnostics Market Outlook, By Urinalysis Testing Kits (2022-2030) ($MN)
10 Global Point-of-Care Diagnostics Market Outlook, By Drug Abuse Testing Kits (2022-2030) ($MN)
11 Global Point-of-Care Diagnostics Market Outlook, By Cardiac Markers (2022-2030) ($MN)
12 Global Point-of-Care Diagnostics Market Outlook, By Thyroid Stimulating Hormone Testing (2022-2030) ($MN)
13 Global Point-of-Care Diagnostics Market Outlook, By Blood Gas/Electrolytes (2022-2030) ($MN)
14 Global Point-of-Care Diagnostics Market Outlook, By Other Product Types (2022-2030) ($MN)
15 Global Point-of-Care Diagnostics Market Outlook, By Platform (2022-2030) ($MN)
16 Global Point-of-Care Diagnostics Market Outlook, By Dipsticks (2022-2030) ($MN)
17 Global Point-of-Care Diagnostics Market Outlook, By Lateral Flow Assays (2022-2030) ($MN)
18 Global Point-of-Care Diagnostics Market Outlook, By Microfluidics (2022-2030) ($MN)
19 Global Point-of-Care Diagnostics Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
20 Global Point-of-Care Diagnostics Market Outlook, By Immunoassays (2022-2030) ($MN)
21 Global Point-of-Care Diagnostics Market Outlook, By Other Platforms (2022-2030) ($MN)
22 Global Point-of-Care Diagnostics Market Outlook, By Prescription (2022-2030) ($MN)
23 Global Point-of-Care Diagnostics Market Outlook, By Prescription Based (2022-2030) ($MN)
24 Global Point-of-Care Diagnostics Market Outlook, By Over The Counter Testing (2022-2030) ($MN)
25 Global Point-of-Care Diagnostics Market Outlook, By Sample (2022-2030) ($MN)
26 Global Point-of-Care Diagnostics Market Outlook, By Blood (2022-2030) ($MN)
27 Global Point-of-Care Diagnostics Market Outlook, By Nasal & Oropharyngeal Swabs (2022-2030) ($MN)
28 Global Point-of-Care Diagnostics Market Outlook, By Urine (2022-2030) ($MN)
29 Global Point-of-Care Diagnostics Market Outlook, By Other Samples (2022-2030) ($MN)
30 Global Point-of-Care Diagnostics Market Outlook, By Application (2022-2030) ($MN)
31 Global Point-of-Care Diagnostics Market Outlook, By Infectious Diseases (2022-2030) ($MN)
32 Global Point-of-Care Diagnostics Market Outlook, By Cardiology (2022-2030) ($MN)
33 Global Point-of-Care Diagnostics Market Outlook, By Diabetes (2022-2030) ($MN)
34 Global Point-of-Care Diagnostics Market Outlook, By Oncology (2022-2030) ($MN)
35 Global Point-of-Care Diagnostics Market Outlook, By Hematology (2022-2030) ($MN)
36 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy & Fertility (2022-2030) ($MN)
37 Global Point-of-Care Diagnostics Market Outlook, By Cholesterol (2022-2030) ($MN)
38 Global Point-of-Care Diagnostics Market Outlook, By Other Applications (2022-2030) ($MN)
39 Global Point-of-Care Diagnostics Market Outlook, By End User (2022-2030) ($MN)
40 Global Point-of-Care Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
41 Global Point-of-Care Diagnostics Market Outlook, By Clinics & Ambulatory Care Centers (2022-2030) ($MN)
42 Global Point-of-Care Diagnostics Market Outlook, By Home Care Settings (2022-2030) ($MN)
43 Global Point-of-Care Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
44 Global Point-of-Care Diagnostics Market Outlook, By Academic & Research Institutes (2022-2030) ($MN)
45 Global Point-of-Care Diagnostics Market Outlook, By Pharmacies (2022-2030) ($MN)
46 Global Point-of-Care Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
